Liposomal Delivery
Phospholipid-based ingredients for formulation work involving wetting, dispersion and content uniformity. Assess vesicle structure and active association from the evidence for the individual product.
Ingredient technologies for formulation
Advanced ingredient technologies for better formulation.
NexaGens develops and supplies liposomal ingredients, functional pellets and microencapsulated ingredients for formulation work involving stability, dispersibility, ingredient protection, sensory performance and release characteristics.
- Liposomal
- Functional pellet
- Microencapsulated
For supplement brands, formulators, manufacturers, procurement teams and distributors.
Ingredient technologies selected by formulation requirement and product-specific evidence.
- Netherlands-based B2B developer and supplier
- Product-specific documentation confirmed per enquiry
- Qualified manufacturing and testing partners
- Final commercial-release review by NexaGens
Technology platforms
Three routes to a better-formulated product
Choose the platform that matches the formulation requirement, then assess the specification and supporting evidence for the individual ingredient.
Functional Pellets
Immediate, four- and eight-hour sustained, enteric, taste-masked and stability-protected multiparticulates, developed to a matched 500–850 µm range for blend uniformity.
Microencapsulation
Food-grade protection against oxidation, light, heat and moisture; taste and odour masking; and oil-to-powder conversion. Products in this range are immediate and non-modified release unless stated otherwise.
Ingredient portfolio
Featured ingredients
Review representative ingredients by technology, technical format and intended formulation role.
Liposomal
Vezicle™ Liposomal Ferric Pyrophosphate
Vezicle™ Liposomal Ferric Pyrophosphate is a phospholipid-based ferric pyrophosphate powder for professional B2B formulation evaluation. Immediate / non-modified release. Request the current specification and...
View specifications
Liposomal
Vezicle™ Liposomal Vitamin K2 MK-7 Powder, NLT 1,500 µg/g
Liposomal Vitamin K2 MK-7 Powder is a single-active, immediate-release ingredient developed for low-dose uniformity and dispersion in professional supplement formulations. It provides NLT 1,500...
View specifications
Functional pellet
PelleTune™ NADH Enteric-Protected Pellets 20% w/w
Single-active enteric functional pellet designed for oxygen and moisture sensitivity and gastric exposure. 20% w/w NADH; enteric / intestinal. NADH Enteric-Protected Pellets 20% w/w...
View specifications
Functional pellet
PelleTune™ Astaxanthin Protected IR Pellets 5% w/w
Single-active stability-protected ir pellet designed for light, oxygen and heat sensitivity without intentional release delay. 5% w/w astaxanthin; protected immediate release; no intentional delay....
View specifications
Microencapsulated
Kapsyra™ Microencapsulated Oregano Oil
Single-active microencapsulated powder designed for volatility, oxidation and strong taste and odour. Assay per finished-product specification; immediate / non-modified. Microencapsulated Oregano Oil supplies Oregano...
View specifications
Microencapsulated
Kapsyra™ Microencapsulated Caffeine (Immediate Release)
Single-active microencapsulated powder designed for bitterness and powder-handling limitations without modifying release. Assay per finished-product specification; immediate / non-modified. Microencapsulated Caffeine (Immediate Release) supplies...
View specificationsProblem-first discovery
What formulation challenge are you solving?
Start with the technical problem when the relevant ingredient technology is not yet clear. Each route leads to an existing NexaGens formulation guide.
01
Solubility and dispersibility
The active will not wet, disperse or stay suspended.
CoQ10, curcumin, carotenoids, vitamin D3, vitamin K2
02Stability protection
Assay drops, colour shifts or the oil goes rancid on storage.
Astaxanthin, lutein, lycopene, CoQ10, NADH, omega-3
03Moisture protection
The blend cakes, clumps or loses activity in humidity.
Choline bitartrate, NADH
04Ingredient interaction protection
One ingredient is degrading another in the same blend.
Iron, vitamin C, oils, sensitive vitamins
05Modified release
The formulation needs release over four or eight hours rather than all at once.
Caffeine, L-theanine
06Enteric and intestinal delivery
The active must survive the stomach and release in the intestine.
Peppermint oil, NADH
07Oil-to-powder conversion
A liquid oil needs to become a manageable, free-flowing powder.
Fish oil, algal DHA, oregano oil, essential oils
Why NexaGens
Defined responsibilities from development to supply
NexaGens B.V. is a Netherlands-based B2B developer and supplier of value-added ingredients, established in 2026. Product development and quality oversight use shared Nova Techs group resources in the Netherlands, supported by qualified external partners.
01
Product development and specifications
NexaGens defines or approves product requirements, technical specifications and acceptance criteria for the ingredients it supplies.
Learn more 02Qualified technical partners
Scale-up, manufacture, analytical testing and specialist characterisation are performed by qualified product-specific partners.
Learn more 03Quality and release oversight
A documented risk-based framework covers qualification, specifications, document control, batch review, traceability and commercial release.
Learn more 04Evaluation to commercial supply
Samples, documentation, availability, packaging, MOQ and lead time are confirmed for the relevant product and commercial requirement.
Learn moreKnowledge Hub
Technical resources for ingredient evaluation
Evidence-led notes for comparing ingredient technologies, terminology and formulation fit.
Microencapsulated Nutraceutical Ingredients: A Formulator’s Guide
Microencapsulation can help nutraceutical formulators address stability, sensory, handling and oil-to-powder challenges. This guide explains what the technology does, where it can help and which technical data buyers...
Read articleMicroencapsulation versus Modified Release: Different Technologies, Different Claims
Not every coated or encapsulated ingredient is a modified-release ingredient. Here is how the two concepts differ and why mixing them up leads to wrong claims.
Read articleWhat Evidence Should Support a Liposomal Powder Claim?
A practical checklist for the characterization and stability data that should sit behind any liposomal delivery claim.
Read articleCommercial evaluation
Ready to evaluate an ingredient?
Tell us the active, dosage form, target market and formulation requirement. We will confirm relevant ingredients, evaluation options and available documentation.